Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation

Published:2018-12 Issue:6 Volume:11 Page:1323-1333
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Ng Hoi Yan,Li Jian,Tao Lihua,Lam Alfred King-Yin,Chan Kwok Wah,Ko Josephine Mun Yee,Yu Valen Zhuoyou,Wong Michael,Li Benjamin,Lung Maria Li

Funder

Innovation and Technology Commission

Lee’s Pharmaceutical (Hong Kong) Limited

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC. CancerBase No. 11;Ferlay,2013

2. Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer;Wang;Semin Cancer Biol,2017

3. Tumour cells resistance in cancer therapy;Martínez-Lacaci;Clin Transl Oncol,2007

4. Cancer immunotherapy—immune checkpoint blockade and associated endocrinopathies;Byun;Nat Rev Endocrinol,2017

5. PD-L1 and survival in solid tumors: a meta-analysis;Wu;PLoS One,2015

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of genomic profiling of patient-matched primary colorectal and surgical resected distant metastatic (stage IV) colorectal carcinoma for drug actionability;Human Pathology;2024-07

2. Modeling Combination Chemo-Immunotherapy for Heterogeneous Tumors;2024-01-08

3. Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinoma;Heliyon;2024-01

4. Comparison of Genomic Profiling of Patient-Matched Primary Colorectal and Surgical Resected Distant Metastatic (Stage IV) Colorectal Carcinoma for Drug Actionability;2024

5. Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer;International Journal of Molecular Sciences;2023-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3